IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow[®] System
· IRRAS has signed a commercial agreement with Medtronic, starting with a pilot phase where Medtronic will have the exclusive right to promote the IRRAflow system in certain sales territories in the United States. · IRRAS will closely support the Medtronic team and remain responsible for customer training activities, order fulfillment, and patient treatment support.Stockholm, November 14, 2022 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced it has signed a Sales Agency Agreement to